Companies: 10,795·Total market cap: $144.5T
Abbott Laboratories

Abbott Laboratories

ABTNYSEHealthcare● Active
$91.07
+$0.29(+0.32%)
Market Cap$158.6B
P/E Ratio
52W High$139.06
52W Low$81.97

Abbott Laboratories (ABT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ABT · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $6.52B for FY2025 (fiscal year ending 2025-12-31), down 51.3% year-over-year. Net profit margin was 14.7%. Based on available data, Abbott Laboratories has been profitable since at least 2011.

FY2025 Net Income$6.52B▼ -51.3% YoY
Trailing 12M (TTM)$6.28Btrailing 4 quarters sum
Net Profit Margin14.7%$6.52B ÷ $44.33B
YoY Change-51.3%
5-Year CAGR+7.7%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · ABT net income history · ABT profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$6.52B▼ 51.3%14.7%
FY2024$13.40B▲ +134.2%31.9%
FY2023$5.72B▼ 17.5%14.3%
FY2022$6.93B▼ 2.0%15.9%
FY2021$7.07B▲ +57.3%16.4%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Abbott Laboratories
Abbott LaboratoriesYOU
ABT
$6.52B-51.3%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Abbott Laboratories (ABT) reported net income of $6.52B for FY2025 (fiscal year ending 2025-12-31), down 51.3% year-over-year. The net profit margin was 14.7% — meaning the company kept $0.15 of every dollar of revenue as profit.

Based on available data, Abbott Laboratories has been profitable since at least 2011. Net income reached a peak of $13.40B in FY2024. Data available for 15 fiscal years.

Abbott Laboratories's net profit margin was 14.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Abbott Laboratories net worth" — the company's market capitalization is a separate figure from ABT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

ABT net income · 5 questions

Abbott Laboratories is profitable. The company reported net income of $6.52B for FY2025, a net profit margin of 14.7%. Net income was down 51.3% year-over-year. Based on available data, Abbott Laboratories has been profitable since at least 2011.

is ABT profitabledoes ABT make a profitABT profitabilityABT profitable company

Source: FMP /income-statement · GAAP · Abbott Laboratories · Abbott Laboratories SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026